Abstract
Accurate surveys are the primary tool for understanding public opinion towards and barriers preventing COVID-19 vaccine uptake. We compare three prominent surveys about vaccination in the US: Delphi-Facebook (n ≈ 250,000 per week), Census Household Pulse (n ≈ 75,000), and Axios-Ipsos (n ≈ 1,000). We find that the two larger surveys are biased compared to the benchmark from the Centers for Disease Control and Prevention (CDC), and that their sample sizes lead to devastating overconfidence in those incorrect estimates. By April 26, 2021, Delphi-Facebook and Census Household Pulse estimated that at least 73% and 69% of US adults had received a first dose of COVID-19 vaccine, which was 16 and 12 percentage points higher, respectively, than the CDC’s estimate (57%). Moreover, estimates of vaccine hesitancy disagree significantly between surveys – we find that these differences cannot be explained entirely by Delphi-Facebook’s under-representation of racial minorities and non-college educated adults. These are examples of the Big Data Paradox1: when a confidence interval based on a large but biased sample exhibits both a seriously displaced center and a grossly underestimated width, thus leading us (confidently) away from the truth. With sufficient attention to quality control, small surveys like Axios-Ipsos can be far more reliable than large ones. We leverage a recently established data quality identity1 to quantify sources of the estimation errors and to conduct a scenario analysis for implications on vaccine willingness and hesitancy. Our study quantifies how bias in large samples can lead to overconfidence in incorrect inferences, which is particularly problematic in studies, like those examined here, that inform high-stakes public policy decisions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
VB is funded by the University of Oxford's Clarendon Fund and the EPSRC and MRC through the OxWaSP CDT programme (EP/L016710/1). SF acknowledges the support of the EPSRC (EP/V002910/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
According to HRA decision tools (http://www.hra-decisiontools.org.uk/research/), our study is considered Research, and according to the NHS REC review tool (http://www.hra-decisiontools.org.uk/ethics/), we do not need NHS Research Ethics Committee (REC) review, as we only used (1) publicly available, (2) anonymized, and (3) aggregated data outside of clinical settings.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Revised and resubmitted to journal. Now 57 pages, 8 figures (including 4 in Appendix). This revision articulates and clarifies methods and interpretation. Empirical findings are unchanged
Data Availability
All data is publicly available from the listed sources.
https://www.ipsos.com/en-us/news-polls/axios-ipsos-coronavirus-index
https://www.census.gov/programs-surveys/household-pulse-survey/data.html
https://cmu-delphi.github.io/delphi-epidata/symptom-survey/contingency-tables.html
https://covid.cdc.gov/covid-data-tracker/#vaccination-trends